Investor Innovation Showcase – J.P. Morgan Healthcare Week 2026
Join the Brisbane, Queensland Investor Innovation Showcase on Monday, 12 January 2026, 9am–12pm, at Marriott Marquis, San Francisco in collaboration with Trade and Investment Queensland and LSN.
Register for the Investor Innovation Showcase today.
Brisbane’s Health Economy
Brisbane’s health ecosystem is a leading destination for clinical trials, commercialisation and export-led growth, backed by significant public investment. The city hosts the largest health cluster in the Southern Hemisphere, offering world-class education and research, strong government support, Australia’s highest density of innovation hubs and a rapidly growing export sector.
- Clinical trials: supported by advanced research infrastructure and a diverse population, Brisbane delivers trials at a cost up to 60% lower than the U.S.
- Health supply chains: major health capital investment and expanding operations are creating new opportunities for private-sector suppliers.
- MedTech/BioTech commercialisation: cutting-edge research and a highly supportive ecosystem position Brisbane as a hotspot for commercialisation.
Brisbane is a leader in medical innovation, producing more than 6,700 health-related graduates each year across medicine, biomedical sciences, engineering, nursing and allied health – feeding into a 190,000-strong health workforce.
Choose Brisbane
To choose Brisbane is to choose Australia. As the 13th largest economy in the world, underpinned by stable governance and 19 Free Trade Agreements, Australia is an unbeatable launchpad for companies looking to expand into the Asia Pacific region.
Brisbane is a leading economic powerhouse recognised as the fastest growing major capital city, with an economy projected to grow to $275 billion by 2041. Brisbane is Australia’s gateway to the Asia Pacific, boasting the closest proximity to the world’s economic growth engine.
Team Queensland has a supportive MedTech and BioTech ecosystem investing in the future. In Brisbane, the Brisbane Economic Development Agency (BEDA) has established a MedTech Initiative that delivers a Global Accelerator program to fast-track investment and open international pathways to strategic partnerships for early-stage ventures; amplifying the highly skilled and educated workforce; and promoting logistic advantages including the close proximity to Asia’s rapidly growing consumer markets. Brisbane is in the driver’s seat to solve global challenges with game-changing impacts.
Read more about Brisbane taking the stage at J.P. Morgan Healthcare Week and Brisbane's Accelerator Model that's raising capital and elevating MedTech in Life Science Nation's Next Phase newsletter.
